Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10273)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
MS4A15
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Stearoyl-CoA desaturase (SCD) [Suppressor]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Target for Ferroptosis | Suppressor | |||
| Responsed Disease | Fibrosarcoma | ICD-11: 2B53 | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
| Cell migration | ||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 |
| Calu-1 cells | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
| MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 | |
| MDA-MB-231 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0062 | |
| HEK-293T cells | Normal | Homo sapiens | CVCL_0063 | |
| NCI-H1975 cells | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
| HeLa cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
| A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
| Response regulation | MS4A15 regulation of anti-ferroptotic lipid reservoirs provides a key resistance mechanism that is distinct from antioxidant and lipid detoxification pathways. And Scd1 and Fads2 are counterregulated with Ms4a15 OE in Fibrosarcoma. | |||
Fibrosarcoma [ICD-11: 2B53]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | Membrane-spanning 4-domains subfamily A member 15 (MS4A15) | Protein coding | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
| Cell migration | ||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 |
| Calu-1 cells | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
| MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 | |
| MDA-MB-231 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0062 | |
| HEK-293T cells | Normal | Homo sapiens | CVCL_0063 | |
| NCI-H1975 cells | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
| HeLa cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
| A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
| Response regulation | MS4A15 regulation of anti-ferroptotic lipid reservoirs provides a key resistance mechanism that is distinct from antioxidant and lipid detoxification pathways. And Scd1 and Fads2 are counterregulated with Ms4a15 OE in Fibrosarcoma. | |||
